Insulin-like growth factor binding protein (IGFBP6) is a cross-species tendon marker.

Turlo, AJ, Mueller-Breckenridge, AJ, Zamboulis, DE ORCID: 0000-0003-2839-7620, Tew, SR ORCID: 0000-0002-1213-5418, Canty-Laird, EG ORCID: 0000-0001-5041-1316 and Clegg, PD ORCID: 0000-0003-0632-0032
(2019) Insulin-like growth factor binding protein (IGFBP6) is a cross-species tendon marker. European Cells and Materials, 38. pp. 123-136.

[thumbnail of Published_eCM.pdf] Text
Published_eCM.pdf - Published version

Download (930kB) | Preview


The main challenge in tendon injury management is suboptimal tissue healing that fails to re-establish original tendon function. Tissue bioengineering is a promising approach for tendon therapy, with potential to improve its functional outcomes. However, evaluation criteria for tissue-engineered tendon are unclear due to the lack of specific markers of differentiated tendon. The study aim was to identify a panel of genes that characterised tendons in comparison to cartilage or muscles and validate those genes, both in human and key species used as models for tendon diseases. Gene expression profiling of rat tendon and cartilage in whole-tissue samples and primary tenocytes and chondrocytes was undertaken using two independent microarray platforms. Genes that demonstrated high expression correlation across two assays were validated by qRT-PCR in rat tendon relative to cartilage and muscle. Five genes demonstrating the highest tendon-related expression in the validation experiment (ASPN, ECM1, IGFBP6, TNMD, THBS4) were further evaluated by qRT-PCR in ovine, equine and human tissue. The group of tendon markers, identified by unbiased transcriptomic analysis of rat musculoskeletal tissues, demonstrated species-dependent profiles of expression. Insulin-like growth factor binding protein 6 (IGFBP6) was identified as the only universal tendon marker. Further investigation in equine tendon showed that IGFBP6 expression was not affected by ageing or tendon function but decreased in anatomical regions subjected to elevated compressive force. IGFBP6 is a robust cross-species marker of tendon phenotype and may find application in evaluation of tendon physiology and guided differentiation of permissive cells towards functional tenocytes.

Item Type: Article
Uncontrolled Keywords: bioengineering, tissue engineering, tendonitis, biomarker, translational biology
Depositing User: Symplectic Admin
Date Deposited: 30 Sep 2019 07:48
Last Modified: 15 Mar 2024 03:36
DOI: 10.22203/ecm.v038a10
Related URLs: